Financial results - G.V.F. PHARMACEUTICAL TECHNOLOGIES SRL

Financial Summary - G.v.f. Pharmaceutical Technologies Srl
Unique identification code: 34181483
Registration number: J2015002579409
Nace: 4614
Sales - Ron
124.335
Net Profit - Ron
41.418
Employees
1
Open Account
Company G.v.f. Pharmaceutical Technologies Srl with Fiscal Code 34181483 recorded a turnover of 2024 of 124.335, with a net profit of 41.418 and having an average number of employees of 1. The company operates in the field of Intermedieri în comerţul cu maşini, echipamente industriale, nave şi avioane having the NACE code 4614.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - G.v.f. Pharmaceutical Technologies Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 3.140 36.927 11.064 111.290 60.631 92.201 115.720 58.339 60.060 124.335
Total Income - EUR 3.167 36.987 11.415 113.055 61.164 94.804 116.000 58.920 60.234 125.424
Total Expenses - EUR 1.555 7.726 7.880 23.576 66.930 83.012 81.219 79.480 56.300 81.158
Gross Profit/Loss - EUR 1.612 29.262 3.534 89.479 -5.766 11.792 34.781 -20.560 3.934 44.266
Net Profit/Loss - EUR 1.517 28.154 3.268 88.349 -6.374 10.926 33.647 -21.144 3.333 41.418
Employees 1 1 1 1 2 3 2 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 108.2%, from 60.060 euro in the year 2023, to 124.335 euro in 2024. The Net Profit increased by 38.103 euro, from 3.333 euro in 2023, to 41.418 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - G.v.f. Pharmaceutical Technologies Srl

Rating financiar

Financial Rating -
G.V.F. PHARMACEUTICAL TECHNOLOGIES...

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
G.v.f. Pharmaceutical Technologies...

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
G.v.f. Pharmaceutical Technologies...

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
G.v.f. Pharmaceutical Technologies...

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - G.v.f. Pharmaceutical Technologies Srl - CUI 34181483

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 0 5.160 4.015 63.304 47.832 33.390 17.944 2.431 3.535 42.091
Current Assets 3.185 23.595 6.654 30.402 40.065 44.929 60.788 50.558 45.909 50.906
Inventories 0 0 0 0 1.929 0 0 0 67 0
Receivables 12 1.707 2.592 8.411 12.945 20.533 40.519 26.538 35.256 33.642
Cash 3.174 21.889 4.062 21.991 25.192 24.395 20.269 24.020 10.585 17.264
Shareholders Funds 1.562 28.199 3.311 91.600 83.452 71.739 72.272 -21.103 -17.706 23.811
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 1.623 557 7.358 2.107 4.445 6.579 6.459 74.092 67.149 69.186
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4614 - 4614"
CAEN Financial Year 4614
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 50.906 euro in 2024 which includes Inventories of 0 euro, Receivables of 33.642 euro and cash availability of 17.264 euro.
The company's Equity was valued at 23.811 euro, while total Liabilities amounted to 69.186 euro. Equity increased by 41.418 euro, from -17.706 euro in 2023, to 23.811 in 2024.

Risk Reports Prices

Reviews - G.v.f. Pharmaceutical Technologies Srl

Comments - G.v.f. Pharmaceutical Technologies Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.